Literature DB >> 7025298

Acute suppurative cholangitis.

E Chock, B M Wolfe, N M Matolo.   

Abstract

Acute suppurative cholangitis is characterized by obstruction, inflammation, and pyogenic infection of the biliary tract associated with the clinical pentad of fever (and chills), jaundice, pain, shock, and central nervous system depression. The disease occurs most commonly in the elderly who have a history of calculous biliary tract disease. The disease represents a true surgical emergency. Appropriate antibiotic therapy and immediate surgical decompression of the biliary tract are essential and carry a mortality rate of approximately 33 per cent. Nonoperative management is uniformly fatal. If inadequately treated or untreated, the disease follows a fulminant course of progressive systemic sepsis, hepatic abscess formation, and heptic failure leading ultimately to death. Acute suppurative cholangitis, the most serious sequela of calculous biliary tract disease, is preventable by early elective surgical treatment for benign biliary tract disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7025298     DOI: 10.1016/s0039-6109(16)42486-2

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  5 in total

Review 1.  Endoscopic management of bile duct stones; (apples and oranges).

Authors:  P B Cotton
Journal:  Gut       Date:  1984-06       Impact factor: 23.059

2.  Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections.

Authors:  M G Bergeron; J Mendelson; G K Harding; L Mandell; I W Fong; A Rachlis; R Chan; S Biron; R Feld; N B Segal
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

3.  Acute cholangitis. Multivariate analysis of risk factors.

Authors:  J F Gigot; T Leese; T Dereme; J Coutinho; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

4.  Common Bile Duct Dilatation With Stones Indicates Requirement for Early Drainage in Patients With or Without Cholangitis.

Authors:  Yasunobu Yamashita; Kazuki Ueda; Hiroko Abe; Takashi Tamura; Masahiro Itonaga; Takeichi Yoshida; Hiroki Maeda; Takao Maekita; Mikitaka Iguchi; Hideyuki Tamai; Masao Ichinose; Jun Kato
Journal:  Gastroenterology Res       Date:  2014-01-15

5.  Efficacy and safety of therapeutic ERCP in patients with ectopic papilla of Vater.

Authors:  Junbo Hong; Weiping Pan; Wei Zuo; Anjiang Wang; Liang Zhu; Xiaodong Zhou; Xiaojiang Zhou; Guohua Li; Zhijian Liu; Pi Liu; Hao Zhen; Yong Zhu; Jiuhong Ma; Jianhui Yuan; Xu Shu; Yin Zhu; Nonghua Lu; Youxiang Chen
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.